Charach G, Rabinovich P, Grosskopf I, Weintraub M
Department of Internal Medicine "C," Tel Aviv Sourasky Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Crit Care Med. 2001 Jun;29(6):1137-44. doi: 10.1097/00003246-200106000-00008.
To evaluate the suitability of the new electrical impedance monitor RS-205 for monitoring of cardiogenic pulmonary edema (CPE).
Prospective, controlled study.
A department of internal medicine in a 1,200-bed university-affiliated, teaching hospital.
Sixty patients, aged 52-80 yrs, 30 without CPE (controls) and 30 with or at high risk for CPE.
Internal thoracic impedance (ITI) was monitored by the RS-205. The RS-205 is approximately three times more sensitive than the Kubicek monitor, and it eliminates the effect of the drift of skin-to-electrode impedance. This is achieved by eliminating skin electrode impedance by a special algorithm, thus allowing measurement of ITI rather than total transthoracic impedance. Measuring ITI, the main component of which is lung impedance, is a noninvasive and safe method. CPE was diagnosed in accordance with well-accepted clinical and roentgenological criteria.
The controls' initial ITI was 68.3 +/- 12.38 ohms. During 6 hrs of monitoring, the ITI attained a minimum average value of -1.3 +/- 2.08% and a maximum average value of 4.6 +/- 3.56% relative to baseline. In all patients entering CPE, ITI decreased by 14.4 +/- 5.42% on the average (p <.001) 1 hr before the appearance of clinical symptoms. In patients with evolving CPE, ITI decreased significantly compared with controls (22.25 +/- 9.82%, p <.001). In patients at the peak of pulmonary edema, ITI was 2.1 times lower than in the control group (33.1 +/- 10.90 ohms, p <.001). In the last hour before the resolution of CPE, ITI increased in all patients by 17.7 +/- 19.74% compared with the peak of disease (p <.05). After the resolution of pulmonary edema, ITI increased in all patients by 44.14 +/- 26.90% compared with the peak of disease (p <.001). Importantly, the trend in ITI in all patients changed in accordance with the dynamics of CPE. A mixed general linear model shows that ITI values correlated well with the degree of crepitation, a direct characteristics of CPE.
The RS-205 is suitable for monitoring patients at high risk of CPE development. It enables detection of CPE and the monitoring of patients at all stages of CPE.
评估新型电阻抗监测仪RS - 205用于监测心源性肺水肿(CPE)的适用性。
前瞻性对照研究。
一所拥有1200张床位的大学附属医院内科。
60例患者,年龄52 - 80岁,30例无CPE(对照组),30例有CPE或有CPE高风险。
采用RS - 205监测胸内阻抗(ITI)。RS - 205的灵敏度约为库比克监测仪的三倍,且消除了皮肤 - 电极阻抗漂移的影响。这是通过一种特殊算法消除皮肤电极阻抗来实现的,从而能够测量ITI而非总胸壁阻抗。测量以肺阻抗为主要成分的ITI是一种无创且安全的方法。CPE根据公认的临床和影像学标准进行诊断。
对照组初始ITI为68.3±12.38欧姆。在6小时的监测期间,ITI相对于基线达到的最小平均值为 - 1.3±2.08%,最大平均值为4.6±3.56%。在所有发生CPE的患者中,ITI在临床症状出现前1小时平均下降14.4±5.42%(p <.001)。在CPE进展期患者中,ITI与对照组相比显著下降(22.25±9.82%,p <.001)。在肺水肿高峰期患者中,ITI比对照组低2.1倍(33.1±10.90欧姆,p <.001)。在CPE消退前的最后1小时,所有患者的ITI与疾病高峰期相比增加了17.7±19.74%(p <.05)。肺水肿消退后,所有患者的ITI与疾病高峰期相比增加了44.14±26.90%(p <.001)。重要的是,所有患者的ITI趋势随CPE动态变化。混合一般线性模型显示,ITI值与啰音程度(CPE的直接特征)相关性良好。
RS - 205适用于监测有CPE发生高风险的患者。它能够检测CPE并对CPE各阶段的患者进行监测。